Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jul;2(4):503-5.
doi: 10.1128/cdli.2.4.503-505.1995.

Immunomodulatory effects of alpha interferon and thymostimulin in patients with neoplasias

I Munno  1 , M Marinaro, A Gesario, B Cannuscio, Y Michel, E Paulling
Affiliations

Immunomodulatory effects of alpha interferon and thymostimulin in patients with neoplasias

I Munno et al. Clin Diagn Lab Immunol. 1995 Jul.

Abstract

In this report, we have evaluated the immunological effects following administration of alpha interferon (IFN-alpha) in combination with thymostimulin (TP-1), as well as of IFN-alpha and TP-1 alone in patients with neoplasias who underwent surgery and were subsequently treated with conventional chemotherapy. Data suggest that the combination of IFN-alpha and TP-1 is the most effective in the up-regulation of some immune parameters such as the CD4(+)-CD8+ cell-dependent antibacterial activity. Since this immune function plays an important role in the host protection against different targets such as invading microorganisms and/or neoplastic cells, the administration of TP-1-IFN-alpha is advisable for patients with neoplasias under chemotherapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Thymic peptides for treatment of cancer patients.
    Wolf E, Milazzo S, Boehm K, Zwahlen M, Horneber M. Wolf E, et al. Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003993. doi: 10.1002/14651858.CD003993.pub3. Cochrane Database Syst Rev. 2011. PMID: 21328265 Free PMC article.

References

    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
    1. J Biol Regul Homeost Agents. 1993 Oct-Dec;7(4):109-14 - PubMed
    1. J Immunol. 1980 Jul;125(1):54-8 - PubMed
    1. Cancer. 1984 Feb 1;53(3 Suppl):783-9 - PubMed
    1. Lancet. 1985 Aug 31;2(8453):505-6 - PubMed